Andreas Harstrick Joins Orion Biotechnology’s Scientific Advisory Board

Ottawa, Canada, Feb. 06, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical-stage company, today announced the addition of Dr. Andreas Harstrick to its Scientific Advisory Board (SAB). Dr. Harstrick brings extensive experience in global cancer drug development from his former positions as SVP Global Clinical Development Oncology at Merck-Serono, SVP Medical Sciences Imclone/Eli Lilly … Read moreAndreas Harstrick Joins Orion Biotechnology’s Scientific Advisory Board

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032